Immature platelet fraction in patients diagnosed with COVID-19

Neha Parashar1, Rashmi J Gupta1, Divya Gupta2

  • 1Department of Clinical Pathology, Lok Nayak Hospital, New Delhi, India.

Insights

COVID-19 patients with low platelet counts showed higher immature platelet fraction (IPF), indicating platelet destruction. This suggests thrombocytopenia in COVID-19 is likely due to peripheral platelet consumption.

Area of Science:

  • Hematology
  • Virology
  • Critical Care Medicine

Background:

  • COVID-19, caused by SARS-CoV-2, is linked to thromboembolic events and thrombocytopenia.
  • Thrombocytopenia can result from increased platelet destruction/consumption or decreased bone marrow production.
  • Immature platelet fraction (IPF) serves as an indicator of peripheral platelet destruction and consumption.

Purpose of the Study:

  • To evaluate the immature platelet fraction (IPF) in patients diagnosed with COVID-19.

Main Methods:

  • Retrospective analysis of laboratory records from 68 COVID-19 patients admitted to a Delhi tertiary care hospital.
  • Platelet parameters including platelet count, mean platelet volume (MPV), IPF, and platelet large cell ratio (P-LCR) were analyzed.
  • Statistical significance was determined using SPSS Version 25, with P < 0.05 considered significant.

Main Results:

  • Mild thrombocytopenia was observed in 40% of COVID-19 patients.
  • Lower platelet counts correlated with significantly higher IPF, MPV, PDW, and P-LCR.
  • A significant inverse relationship was found between IPF and platelet count (P < 0.05).
  • IPF showed a significant positive correlation with MPV and P-LCR (P < 0.05).

Conclusions:

  • Thrombocytopenia in COVID-19 patients is likely attributed to peripheral platelet destruction and consumption.
  • Elevated IPF levels may serve as a biomarker for platelet consumption in COVID-19-associated thrombocytopenia.
Abstract